Previous 10 | Next 10 |
Stock valuations are collapsing while earnings are improving, according to Credit Suisse. "While the median company has seen their stock price fall -24.4% since its peak, the median P/E multiple fell -27.5%," strategist Jonathan Golub wrote in a note. "This difference is explained by a health...
Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Investors enjoyed a breather this week from the market's April-and-May selloff that had taken the Nasdaq Composite solidly into bear territory and the S&am...
DexCom (NASDAQ: DXCM) shares are lower to the tune of 11.4% as of 12:40 p.m. ET today, according to data from S&P Global Market Intelligence , caught up in a broad sell-off. Reports that it's mulling an acquisition of Insulet (NASDAQ: PODD) may be exacerbating the we...
Uber (NYSE:UBER) was among the standout decliners on an overall weak day for the market, dropping in Tuesday's midday trading following a cautious analyst comment. INmune Bio (INMB) also suffered an intraday slide, losing around a quarter of its value on a regulatory setback. Meanwhile,...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Insulet (NASDAQ: PODD ) stock is jumping on acquisition reports. DexCom (NASDAQ: DXCM ) reportedly wants to buy the company. This would create a major contender in the diabetes device market. Source: M...
Commenting on the reports that the medical device company DexCom (NASDAQ:DXCM) is in talks to acquire the insulin pump maker Insulet (NASDAQ:PODD), a group of analysts at Bank of America argues that a deal between the two diabetes players is unlikely. The Bloomberg report about disc...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Insulet (NASDAQ: PODD ) stock leads our gainers with an 11% increase. Pinterest (NYSE: PINS ) stock is our biggest loser with a 12% drop. Acquisition news, earnings reports, and more have stocks moving toda...
On May 15, institutional investment managers with more than $100 million AUM had to disclose their positions at the end of Q1 2022. I curated a list of some of the best-performing hedge funds of the past few years and looked into their holdings at the end of March 2022. Most tech ...
Biopharmaceutical stocks have undergone a dramatic correction over the past six months, with the XBI declining by 45%. The decline was appropriate, given the number of companies that went public in 2021 with preclinical data and a valuation exceeding $1 billion. Not only would the...
In its recent 13-F filing, Coatue Management indicated a fund value total of $13.7B wherein it acquired new stakes in Lucid (LCID) with 2.97M shares, Zillow (ZG) with 2.36M shares, Docusign (DOCU) with 1.46M shares, AMC Entertainment (AMC) with 5.19M shares and Beyond Meat (BYND) with 5M shar...
News, Short Squeeze, Breakout and More Instantly...
2024-07-04 10:00:00 ET Growth-oriented investors have experienced a bit of a roller-coaster ride over the past few years. Many companies in the "growth stock" category were struggling just two years ago, but in the bull market we are now experiencing, they're delivering very different resul...
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2024 financial results after market close on Thursday, July 25, 2024. Management will hold a conference call to review the company's second quarter 2024 performance starting at 4:30 p.m. (Eastern Time) on the...